Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV.

Nerve growth factor (NGF) is a neurotrophin with the ability to exert specific effects on cells of the immune system. Human monocytes/macrophages (M/M) infected in vitro with HIV type 1 (HIV-1) are able to produce substantial levels of NGF that are associated with enhanced expression of the high-affinity NGF receptor (p140 trkA) on the M/M surface. Treatment of HIV-infected human M/M with anti-NGF Ab blocking the biological activity of NGF leads to a marked decrease of the expression of p140 trkA high-affinity receptor, a concomitant increased expression of p75(NTR) low-affinity receptor for NGF, and the occurrence of apoptotic death of M/M. Taken together, these findings suggest a role for NGF as an autocrine survival factor that rescues human M/M from the cytopathic effect caused by HIV infection.

[1]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[2]  W. R. Epa,et al.  Nerve Growth Factor Determines Survival and Death of PC12 Cells by Regulation of the bcl‐x, bax, and caspase‐3 Genes , 1999, Journal of neurochemistry.

[3]  A. Stalder,et al.  Expression of functional trk protooncogene in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Woolf,et al.  Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α , 1997, British journal of pharmacology.

[5]  K. Wolff,et al.  Epidermal Langerhans cells--a target for HTLV-III/LAV infection. , 1987, The Journal of investigative dermatology.

[6]  Manuel Buttini,et al.  An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. , 1997, Journal of neurovirology.

[7]  R. Jaenisch,et al.  p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF. , 1994, Development.

[8]  D. Brahams.  Latent Drug Injury: Failure of Dutch Diethylstilboestrol Action , 1988, The Lancet.

[9]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[10]  M. Popovič,et al.  ISOLATION OF HIV-1 FROM MONOCYTES BUT NOT T LYMPHOCYTES , 1987, The Lancet.

[11]  H. Gendelman,et al.  A model of human immunodeficiency virus encephalitis in scid mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Gee,et al.  Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Bradshaw,et al.  The receptors for nerve growth factor and other neurotrophins. , 1993, Annual review of biochemistry.

[14]  R. Levi‐montalcini,et al.  Mast cells increase in tissues of neonatal rats injected with the nerve growth factor , 1977, Brain Research.

[15]  E. Coligan.  Current protocols in immunology , 1991 .

[16]  K. Kawamoto,et al.  Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. , 1995, Blood.

[17]  S. Aquaro,et al.  Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. , 1998, The Journal of infectious diseases.

[18]  M. Clementi,et al.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo , 1996, Journal of virology.

[19]  L. Nencioni,et al.  Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes , 1996, Cell.

[20]  R. Stein,et al.  Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells , 1999, Journal of neuroscience research.

[21]  C. Buttinelli,et al.  Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid , 1992, Neuroscience Letters.

[22]  C. Fox,et al.  Macrophages as a source of HIV during opportunistic infections. , 1997, Science.

[23]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[24]  N. Assa‐Munt,et al.  p75NTR and the concept of cellular dependence: seeing how the other half die , 1998, Cell Death and Differentiation.

[25]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[26]  M. McElrath,et al.  Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Gendelman,et al.  Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. , 1990, AIDS research and human retroviruses.

[28]  G. Nisticó,et al.  Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Kilpatrick,et al.  Nerve Growth Factor Signaling through p75 Induces Apoptosis in Schwann Cells via a Bcl-2-Independent Pathway , 1999, The Journal of Neuroscience.

[30]  J. Perez-polo,et al.  The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes , 1987, Journal of neuroscience research.

[31]  L. Aloe.  Intraocular herpes simplex virus injection in neonatal rats induces sympathetic nerve cell destruction: Effect of nerve growth factor , 1987, International Journal of Developmental Neuroscience.

[32]  A. Bertoli,et al.  Clinical implications of HIV dynamics and drug resistance in macrophages. , 1998, Journal of biological regulators and homeostatic agents.

[33]  D. Giulian,et al.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.

[34]  M. Hirsch,et al.  Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.

[35]  M. Hirsch,et al.  Immunohistochemical identification of HTLV‐III antigen in brains of patients with AIDS , 1986, Annals of neurology.

[36]  F. Poccia,et al.  Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Wilcox,et al.  Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro , 1987, Journal of virology.

[38]  M. Chao,et al.  Neurotrophins: the biological paradox of survival factors eliciting apoptosis , 1998, Cell Death and Differentiation.

[39]  C. Wilcox,et al.  Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro , 1988, Journal of virology.

[40]  D. Hazen-martin,et al.  Immunocytochemical localization of nerve growth factor: effects of fixation. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  S. Chevalier,et al.  Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. , 1996, Blood.

[42]  H. Thompson,et al.  Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. , 1986, The Journal of physiology.

[43]  Y. Kitamura,et al.  Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells , 1991, The Journal of experimental medicine.

[44]  B. Hempstead,et al.  p75 and Trk: A two-receptor system , 1995, Trends in Neurosciences.

[45]  H. Gendelman,et al.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.

[46]  D. Markovitz,et al.  The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.

[47]  D. Kaplan,et al.  The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. , 1991, Science.

[48]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[49]  M. Barbacid,et al.  Molecular and biochemical characterization of the human trk proto-oncogene , 1989, Molecular and cellular biology.

[50]  C. Thiele,et al.  HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. , 1994, Virology.

[51]  H. Farzadegan,et al.  Localization of human immunodeficiency virus core antigen in term human placentas. , 1992, Pediatrics.

[52]  H. Thoenen,et al.  PURIFICATION OF NERVE GROWTH FACTOR ANTIBODIES BY AFFINITY CHROMATOGRAPHY , 1976, Journal of neurochemistry.

[53]  S. Bonini,et al.  The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases , 1997, Allergy.

[54]  S. Shimizu,et al.  Nerve growth factor suppresses apoptosis of murine neutrophils. , 1992, Biochemical and biophysical research communications.

[55]  B. Bloch,et al.  Distribution of NGF receptors in normal and pathologic human lymphoid tissues , 1997, Journal of Neuroimmunology.

[56]  D. Smith,et al.  Fas ligand deficiency in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[58]  R. Harris-Warrick,et al.  Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. , 1979, The Journal of biological chemistry.

[59]  N. Brousse,et al.  AIDS subacute encephalitis. Identification of HIV-infected cells. , 1987, The American journal of pathology.

[60]  K. Kawamoto,et al.  Functional properties of murine macrophages promoted by nerve growth factor. , 1996, Blood.

[61]  S. Bonini,et al.  Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. , 1997, The Journal of allergy and clinical immunology.

[62]  G. Childs,et al.  Nerve growth factor in the anterior pituitary: regulation of secretion. , 1994, Endocrinology.